Skip to main content

Articles

Page 1 of 16

  1. With the first domestic 9-valent human papillomavirus (HPV) vaccine soon to be introduced in China, alongside advancements in cervical cancer screening technologies, we aimed to evaluate and identify effective...

    Authors: Dachuang Zhou, Di Zhang, Yi Wang, Kejia Zhou and Wenxi Tang
    Citation: Cost Effectiveness and Resource Allocation 2025 23:20
  2. This paper argues that in many contexts where effectiveness analysis such as benefit-cost analysis and cost-effectiveness analysis is used, we have good reason to think that some benefits or costs are incommen...

    Authors: Anders Herlitz
    Citation: Cost Effectiveness and Resource Allocation 2025 23:19
  3. Pediatric pneumonia remains a major cause of morbidity and mortality, imposing substantial financial burdens on healthcare systems and families. This study evaluates the impact of China’s diagnosis-interventio...

    Authors: Liang Zhao, Kun Zeng, Feijia Chen, Wei Li and Jun Zhao
    Citation: Cost Effectiveness and Resource Allocation 2025 23:18
  4. The increase in longevity determines a greater need to receive medical care and pharmacological treatments. The introduction of patient cost-sharing in pharmaceutical expenditures aims to finance the National/...

    Authors: Leonarda Maurmo, Federico Ruta, Grazia Dicuonzo, Vincenzo Signoretta, Cosimo Gennari, Vincenzo Dicuonzo, Donato Suma, Mariarosaria D’Ambrosio and Cataldo Procacci
    Citation: Cost Effectiveness and Resource Allocation 2025 23:17
  5. Olaparib, an inhibitor of poly (ADP-ribose) polymerase (PARP), has demonstrated promising outcomes in treating HER2-negative early-stage breast cancer with BRCA mutations. However, a comprehensive evaluation o...

    Authors: Chenxia Xu, Jie Zhuang, Jianrong Shen, Hong Sun, Jiaqin Cai and Xiaoxia Wei
    Citation: Cost Effectiveness and Resource Allocation 2025 23:16
  6. Health Economic Evaluations (HEEs) provide the necessary evidence of cost–benefit to inform policy and investment decisions. No HEEs have quantified the cost–benefit of passive suction (PS) vs vacuum assisted ...

    Authors: Leigh Clarke, Alan Shiell and Michael P. Dillon
    Citation: Cost Effectiveness and Resource Allocation 2025 23:15
  7. This research aimed to determine the cost-effectiveness of nephroprotection programs compared to no intervention in adults with type 2 diabetes mellitus (T2DM) in the Colombian national health system.

    Authors: Cristian Alejandro González-Rojas, Sergio Augusto Cáceres-Maldonado, Luis Alberto Soler-Vanoy and Lizbeth Alexandra Acuña-Merchán
    Citation: Cost Effectiveness and Resource Allocation 2025 23:14
  8. The implementation of targeted drug therapy results in a significant improvement in both survival rates and quality of life among patients diagnosed with pulmonary arterial hypertension (PAH), concurrently imp...

    Authors: Wenxing Dong, Zhe Zhang, Xiaodan Wang, Xiaolong Ma, Mingming Chu, Yulian Li, Xing Xiang, Cheng Peng and Rong Zhang
    Citation: Cost Effectiveness and Resource Allocation 2025 23:13
  9. In Ethiopia, out-of-pocket medical expenses make up one-third of all medical expenses, which makes it difficult for households to obtain and utilize healthcare. One of the prepayment mechanisms that shield low...

    Authors: Abdene Weya Kaso, Berhanu Gidisa Debela, Habtamu Endashaw Hareru, Helen Ali Ewune, Mary Abera Debisa, Daniel Sisay and Alemayehu Hailu
    Citation: Cost Effectiveness and Resource Allocation 2025 23:12
  10. While studies have reported a positive association between medical insurance and life satisfaction, there is a lack of studies assessing the underlying impact mechanism. The present study aims to investigate t...

    Authors: Jian Sun, Peter C. Coyte, Yujiang Liu and Qianqiang Wang
    Citation: Cost Effectiveness and Resource Allocation 2025 23:10
  11. In the current cost management model of public hospitals, decision-making heavily relies on the subjective judgment of managers, resulting in a 12.9% cost overrun compared to the budget in 2020 at a tertiary h...

    Authors: Zhihao Yu, Guangning Sun, Shuaijun Lin, Haoqian Hu and Jing Xu
    Citation: Cost Effectiveness and Resource Allocation 2025 23:11
  12. Type 1 Diabetes Mellitus (T1DM) is a life-threatening condition that is managed with administered insulin. Intermediate- to long-acting insulin represents the basal insulin constituent of the total insulin use...

    Authors: Mark T. Verryn and Susan Cleary
    Citation: Cost Effectiveness and Resource Allocation 2025 23:9
  13. The EVER-132-002 trial demonstrated the significant efficacy and manageable safety of sacituzumab govitecan in hormone receptor-positive human epidermal growth factor receptor 2-negative (HR + HER2-) metastati...

    Authors: Shixian Liu, Kaixuan Wang, Hao Chen, Ziming Wan, Lei Dou and Shunping Li
    Citation: Cost Effectiveness and Resource Allocation 2025 23:8
  14. Financial risk protection is one of the main goals of healthcare systems worldwide and prepayment system plays an important role to achieve it. There are some prepayment schemes, and Individual voluntary priva...

    Authors: Rajabali Daroudi, Reza Hashempour, Behzad Raei, Sajad Ramandi, Kamran Irandoust, Ali Kazemi-Karyani, Nasrin Abolhasanbeigi Gallehzan, Jafar Yahyavi Dizaj and Marjan Darabi
    Citation: Cost Effectiveness and Resource Allocation 2025 23:7
  15. Renal insufficiency is one of the most common complications in the treatment of multiple myeloma (MM). The administration of isatuximab showed improved patient outcome regarding the occurrence of renal insuffi...

    Authors: F. Jakobs, P. Ahmadi, V. Osterkamp, J. Jeck, U. Holtick, C. Scheid and Florian Kron
    Citation: Cost Effectiveness and Resource Allocation 2025 23:6
  16. Nirmatrelvir/ritonavir is indicated for the treatment of COVID-19 in symptomatic adults with increased risk for severe illness, not requiring supplemental oxygen yet. From a Dutch societal perspective, a cost-...

    Authors: Carlos H. Arteaga Duarte, Michel L. Peters, Michelle H. M. de Goeij, Roy Spijkerman and Maarten J. Postma
    Citation: Cost Effectiveness and Resource Allocation 2025 23:5
  17. As health expenditure continues to rise due to income growth, technological advancements, and an aging population, it has become increasingly important to accurately measure and improve the efficiency of healt...

    Authors: Yejin Joo
    Citation: Cost Effectiveness and Resource Allocation 2025 23:4
  18. Inherited metabolic disorders (IMDs) are a significant cause of morbidity and death among children. To determine the cost-effectiveness of newborn screening for IMDs using tandem mass spectrometry (MS/MS) comp...

    Authors: Dunming Xiao, Jiaqi Yuan, Shimeng Liu, Yi Yang and Yingyao Chen
    Citation: Cost Effectiveness and Resource Allocation 2025 23:3
  19. Changes in the demand behavior for primary care during the covid-19 pandemic may translate into changes in the overall public health situation in Iran with the increase in the prevalence of non-communicable di...

    Authors: Mohsen Bayati, Farhad Lotfi, Mehdi Bayati and Zahra Goudarzi
    Citation: Cost Effectiveness and Resource Allocation 2025 23:2
  20. Childhood cancer is not a high priority in health care financing for many countries, including in Ghana. Delayed care seeking and treatment abandonment, often due to the financial burden of care seeking to fam...

    Authors: Richmond Owusu, Dakota Pritchard, Lieke Fleur Heupink, Godwin Gulbi, Brian Asare, Ivy Amankwah, Joycelyn Azeez, Martha Gyansa-Lutterodt, Lydia Dsane-Selby, Ruby Aileen Mensah, William Omane-Adjekum, Francis Ruiz, Mohamed Gad, Justice Nonvignon and Lumbwe Chola
    Citation: Cost Effectiveness and Resource Allocation 2025 23:1
  21. The PECUNIA Project was funded by the H2020 programme in which 10 partners from six countries participated. The aim was to develop standardized, harmonized and validated methods and tools to calculate costs in...

    Authors: Lidia García-Pérez, Renata Linertová, Aránzazu Hernández-Yumar, Cristina Valcárcel-Nazco, Jhoner Perdomo-Vielma, Pedro Serrano-Aguilar, Mencia R. Gutierrez-Colosia, Luis Salvador-Carulla, Enrique Fernández-Vega, Susanne Mayer and Judit Simon
    Citation: Cost Effectiveness and Resource Allocation 2024 22:92
  22. The cost accounting of medical service projects forms the basis for disease cost accounting and DRG (Diagnosis-Related Groups) cost accounting. Among the various costs involved, human resources represent a sig...

    Authors: Yingqi Li, Siyuan Liang, Kui Qin, Hongtong Su and Peiyong Xia
    Citation: Cost Effectiveness and Resource Allocation 2024 22:91
  23. Risk prediction tools are widely used in healthcare to identify individuals at high risk of adverse events who may benefit from proactive interventions. Traditionally, these tools are evaluated primarily on st...

    Authors: Steven Wyatt, Mohammed A. Mohammed and Peter Spilsbury
    Citation: Cost Effectiveness and Resource Allocation 2024 22:90
  24. Madagascar has made significant progress in the fight against malaria. However, the number of malaria cases yearly increased since 2012. ITNs and IRS are key interventions for reducing malaria in Madagascar. G...

    Authors: Voahirana Tantely Annick Andrianantoandro, Martine Audibert, Thomas Kesteman, Léonora Ravolanjarasoa, Milijaona Randrianarivelojosia and Christophe Rogier
    Citation: Cost Effectiveness and Resource Allocation 2024 22:89
  25. Health financing system in Tanzania changed in the early 1990s as a result of the introduction of cost-sharing policies by the 1990s health sector reforms. The reforms brought about user fees which has led to ...

    Authors: Malale Tungu, Nathanael Sirili, Alphoncina Kagaigai, Pankras Luoga, Novatus Tesha, Thadeus Ruwaichi and Gasto Frumence
    Citation: Cost Effectiveness and Resource Allocation 2024 22:88
  26. Assessment of the cost-related burden of chronic diseases is important for making informed decisions. An effective and efficient methodology for examining medical expenditures is one of the most significant ch...

    Authors: Akemat Wongpairin, Apiradee Lim, Phattrawan Tongkumchum, Wichayaporn Thongpeth and Haris Khurram
    Citation: Cost Effectiveness and Resource Allocation 2024 22:87
  27. Equity and efficiency are two fundamental principles for the sound development of health systems, as advocated by the World Health Organization (WHO). Despite the notable progress made by the Association of So...

    Authors: Yaqing Liu, Liwen Gong, Haoran Niu, Feng Jiang, Sixian Du and Yiyun Jiang
    Citation: Cost Effectiveness and Resource Allocation 2024 22:86
  28. Owing to the lack of local cost and clinical effectiveness data in sub-Saharan Africa, economic evaluations of the rotavirus vaccine are still limited in the region. In this study, we utilize different data so...

    Authors: Rornald Muhumuza Kananura, Gatien de Broucker, Anthony Ssebagereka, Aloysius Mutebi, Elizabeth Ekirapa Kiracho and Bryan Patenaude
    Citation: Cost Effectiveness and Resource Allocation 2024 22:85
  29. This study investigated the cost-effectiveness of using fenofibrate to treat type 2 diabetes in Australia. The financial burden of type 2 diabetes mellitus is estimated to surpass AUD10 billion, mainly due to ...

    Authors: Hansoo Kim, Juntao Lyu, Vikrama Raja and Kyoo Kim
    Citation: Cost Effectiveness and Resource Allocation 2024 22:84
  30. Despite the growing evidence on efficacy, little is known regarding the efficiency of Vitamin D supplementation (VDS) to reduce the incidence of repeat episodes of pneumonia in children. This study aimed to de...

    Authors: Jefferson Antonio Buendía and Diana Guerrero Patiño
    Citation: Cost Effectiveness and Resource Allocation 2024 22:83
  31. This study aimed to determine the cost-effectiveness of Tocilizumab (TCZ) compared with Adalimumab (ADA) in patients with Rheumatoid Arthritis (RA), who had not responded to methotrexate (MTX), from a societal...

    Authors: Yalda Metghalchi, Neda Yaghoubi, Nazila Yousefi, Razieh Ahmadi, Alireza Kargar, Marzieh Zargaran and Soheila Rezaei
    Citation: Cost Effectiveness and Resource Allocation 2024 22:82
  32. Enhancing efficiency is crucial in addressing the escalating scarcity of healthcare resources. It plays a pivotal role in achieving Universal Health Coverage (UHC), with the ultimate goal of ensuring health eq...

    Authors: Alireza Olyaeemanesh, Farhad Habibi, Mohammadreza Mobinizadeh, Amirhossein Takian, Bahman Khosravi, Jawad Jafarzadeh, Ahad Bakhtiari and Efat Mohamadi
    Citation: Cost Effectiveness and Resource Allocation 2024 22:81
  33. Scaling up public health interventions in the health systems of resource poor settings come with technical and operational challenges. Little is documented on scaling up complex health financing interventions ...

    Authors: Ntuli A. Kapologwe, Boniphace Marwa, Heri Marwa, Ally Kebby, James Tumaini Kengia, George Ruhago, Stephen M. Kibusi, Innocent B. Mboya, Gemini Mtei and Albino Kalolo
    Citation: Cost Effectiveness and Resource Allocation 2024 22:80
  34. Dynamic transmission models are often used to provide epidemiological guidance for pandemic policy decisions. However, how economic evaluation is typically incorporated into this technique to generate cost-eff...

    Authors: Shania Rossiter, Samantha Howe, Joshua Szanyi, James M. Trauer, Tim Wilson and Tony Blakely
    Citation: Cost Effectiveness and Resource Allocation 2024 22:77
  35. Decentralisation has increasingly been adopted by countries as an important health sector reform aimed at increasing community participation in decision making while enhancing swift response at decentralised l...

    Authors: Alex Olateju Adjagba, James Odhiambo Oguta, Catherine Akoth, Elvis Omondi Achach Wambiya, Justice Nonvignon and Debra Jackson
    Citation: Cost Effectiveness and Resource Allocation 2024 22:76
  36. The knee is the most commonly afflicted weight-bearing joint. Osteoarthritis of the knee is regarded as one of the most commonly diagnosed causes of disability in the elderly. Knee joint replacement can be reg...

    Authors: Marziyeh Rajabi, Elahe Pourahmadi, Amin Adel and Asma Rashki Kemmak
    Citation: Cost Effectiveness and Resource Allocation 2024 22:74
  37. The viability of community-based health insurance programs depends on beneficiary satisfaction, and healthcare systems evaluate performance through patient reports and ratings to ensure effectiveness and servi...

    Authors: Ewunetie Mekashaw Bayked, Husien Nurahmed Toleha, Segenet Zewdie, Asnakew Molla Mekonen, Birhanu Demeke Workneh and Mesfin Haile Kahissay
    Citation: Cost Effectiveness and Resource Allocation 2024 22:73
  38. Around 60% of term labours in the UK are continuously monitored using cardiotocography (CTG) to guide clinical labour management. Interpreting the CTG trace is challenging, leading to some babies suffering adv...

    Authors: H. E. Campbell, S. Ratushnyak, A. Georgieva, L. Impey and O. Rivero-Arias
    Citation: Cost Effectiveness and Resource Allocation 2024 22:72
  39. Web of Science, Cochrane library and PubMed were systematically searched up to January 2024 to identify studies examining the impact of financial incentives on diabetes management in patients. Studies were eva...

    Authors: Qingqing Zhang, Xue Wei, Jing Zheng, Yu Lu and Yucheng Wu
    Citation: Cost Effectiveness and Resource Allocation 2024 22:71
  40. The cost-effectiveness of NALIRIFOX as a potential new standard of care for patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) has yet to be established. Our objective was to evaluate the cost-e...

    Authors: Hanqiao Shao, Hongshu Fang, Yuan Li, Yunlin Jiang, Mingye Zhao and Wenxi Tang
    Citation: Cost Effectiveness and Resource Allocation 2024 22:70
  41. Anaemia among women of reproductive age (WRA) remains persistently high in Ghana, affecting 41% in 2022. Women in low-income communities in Ghana engaged in fish processing activities are at increased risk of ...

    Authors: Francis Adane, Richmond Aryeetey, Genevieve Aryeetey and Justice Nonvignon
    Citation: Cost Effectiveness and Resource Allocation 2024 22:69

    The Correction to this article has been published in Cost Effectiveness and Resource Allocation 2024 22:79

  42. Cost-effectiveness analysis (CEA) has become a crucial technique in appraising the efficiency of healthcare interventions and resource allocation decisions. Cost-effectiveness analysis is now widely used to ev...

    Authors: Kemdi Lugard Okoroiwu, Henshaw Uchechi Okoroiwu, Love Ogochukwu Ude, Chidimma Odilia Ezuma and Emmanuel Ikechukwu Omeje
    Citation: Cost Effectiveness and Resource Allocation 2024 22:68

    The Correction to this article has been published in Cost Effectiveness and Resource Allocation 2024 22:78

  43. Understanding the technical efficiency of health facilities is essential for an optimal allocation of scarce resources to primary health sectors. The COVID-19 pandemic may have further undermined levels of eff...

    Authors: Gordon Abekah-Nkrumah, Charles Gyamfi Ofori, Maxwell Antwi, Alex Yao Attachey, Tobias F. Rinke de Wit, Wendy Janssens, James Duah, Charlotte Dieteren and Gifty Sunkwa-Mills
    Citation: Cost Effectiveness and Resource Allocation 2024 22:67
  44. This study assessed the cost-effectiveness of proton beam therapy (PBT) compared to conventional radiotherapy (CRT) for treating patients with brain tumors in Sweden.

    Authors: Filipa Sampaio, Ulrica Langegård, Patricio Martínez de Alva, Sergio Flores, Camilla Nystrand, Per Fransson, Emma Ohlsson-Nevo, Ingrid Kristensen, Katarina Sjövall, Inna Feldman and Karin Ahlberg
    Citation: Cost Effectiveness and Resource Allocation 2024 22:66
  45. Since December 2021, Wuxi, China has offered a two-dose human papillomavirus (HPV) vaccination to 14-year-old females for free. This study evaluated the costs and benefits of this vaccination scheduled in the ...

    Authors: Jingfeng Jiang, Fanqi Zhao, Xiang Hong and Xuwen Wang
    Citation: Cost Effectiveness and Resource Allocation 2024 22:64
  46. Early detection through screening dramatically improves lung cancer survival rates, including among war Veterans, who are at heightened risk. The effectiveness of low dose computed tomography scans in lung can...

    Authors: Aparna Reddy, Fumiya Abe-Nornes, Alison Haskell, Momoka Saito, Matthew Schumacher, Advaidh Venkat, Krithika Venkatasubramanian, Kira Woodhouse, Yiran Zhang, Hooman Niktafar, Anthony Leveque, Beth Kedroske, Nithya Ramnath and Amy Cohn
    Citation: Cost Effectiveness and Resource Allocation 2024 22:63
  47. Treatment cost and high prevalence of Poly Cystic Ovarian Syndrome (PCOS) is a very challenging issue globally. Due to this reason; current study was conducted to determine pharmaco-economy of conventional and...

    Authors: Darakhshan Masroor, Sheikh Abdul Khaliq, Syed Muzzammil Ahmad, Farah Mazhar and Iqbal Azhar
    Citation: Cost Effectiveness and Resource Allocation 2024 22:62

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 1.7
    5-year Journal Impact Factor: 2.1
    Source Normalized Impact per Paper (SNIP): 0.749
    SCImago Journal Rank (SJR): 0.610

    Speed 2024
    Submission to first editorial decision (median days): 10
    Submission to acceptance (median days): 168

    Usage 2024
    Downloads: 550,922
    Altmetric mentions: 312